Articles tagged "Kidney"

2020 American Transplant Congress
Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA
K. K. Sureshkumar, B. Chopra
Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA
*Purpose: Donor derived-cell free DNA (dd-cfDNA) is a biomarker useful in predicting acute rejection in renal allografts. The technology uses next generation sequencing and does…
2020 American Transplant Congress
Prevalence of Kidney Transplant-Associated Thrombotic Microangiopathy after ABO-Incompatible Kidney Transplantation
Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Thrombotic microangiopathy (TMA) is a dangerous disorder characterized by fragmented red blood cells, decreased platelet count, and organ failure due to thrombosis. We investigated…
2020 American Transplant Congress
A Novel Polymer Product, APP-103, Reduces IRI-Induced Damage and Promotes Functional Improvement in Syngeneic Models of Renal Transplantation
K. Minami¹, S. Bae², H. Uehara¹, J. Iske¹, J. Reder³, H. Azuma⁴, A. Weins¹, E. Van Keuren⁵, B. Houser³, A. El-Khal¹, P. Kang², S. Tullius¹
¹Brigham and Women's Hospital, Boston, MA, ²Beth Israel Deaconess Medical Center, Boston, MA, ³Celdara Medical, Lebanon, NH, ⁴Osaka Medical College, Osaka, Japan, ⁵Georgetown University, Washington DC, DC
*Purpose: Our data introduce APP-103 as a novel, non-toxic and site-activating therapeutic approach that effectively ameliorates the consequences of ischemia/reperfusion injury in solid organ transplantation.*Methods:…
2020 American Transplant Congress
HIV+ Living Kidney Donors in the United States: Cases and a Clinical Paradigm
D. Segev¹, C. Wolfe², D. Brown³, D. Fine³, K. Neumann⁴, N. Martinez⁵, D. Ostrander³, F. Al Ammary³, A. Tobian³, A. W. Baker⁶, C. Durand³
¹Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD, ²Duke University Medical Center, Durham, NC, ³Johns Hopkins University, School of Medicine, Baltimore, MD, ⁴Unaffiliated, N/A, VA, ⁵Unaffiliated, N/A, GA, ⁶Duke University, School of Medicine, Durham, NC
*Purpose: To report clinical characteristics and outcomes of two people living with HIV who underwent laparoscopic donor nephrectomy*Methods: To facilitate donor selection, we first conducted…
2020 American Transplant Congress
The Influence of the Donor Kidney Weight to Recipient Body Weight Ratio on Long-Term Renal Graft Outcomes
S. Yang¹, J. Lee¹, Y. Jung², B. Kim³, M. Kim¹, S. Kim¹, Y. Kim¹, K. Huh¹
¹Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Nephrology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: To study the impact of the relative donor kidney size on long-term graft function and survival, we investigated the living donor renal transplants outcomes.*Methods:…
2020 American Transplant Congress
Torque Teno Virus for Risk Stratification of Graft Rejection and Infection in Kidney Transplant Recipients – A Prospective Observational Trial
K. Doberer, G. Böhmig, E. Puchhammer, G. Bond
Medical University Vienna, Vienna, Austria
*Purpose: The non-pathogenic and ubiquitous Torque Teno virus (TTV) is associated with immunosuppression in solid organ transplant recipients. This trial was designed to assess the…
2020 American Transplant Congress
7-Years Retrospective Cohort of CNI to Belatacept Conversion
A. Morel¹, C. Dudreuilh¹, A. Moktefi², D. Kheav³, D. Mokrani¹, K. El Sakhawi¹, C. Champy⁴, P. Rémy¹, P. Grimbert¹, M. Matignon¹
¹Nephrology, APHP Henri Mondor, Créteil, France, ²Anatomopathology, APHP Henri Mondor, Créteil, France, ³Immunology, APHP Saint Louis, Paris, France, ⁴Urology, APHP Henri Mondor, Créteil, France
*Purpose: Analyze the long-term evolution after calcineurin inhibitors (CNIs) to Belatacept conversion in kidney allograft recipients.*Methods: In this single-center retrospective study, we collected all patients…
2020 American Transplant Congress
HLA-DQ Plays an Important Role in Graft Survival in African American Transplant Recipients
L. M. Rebellato¹, W. Irish², D. Leeser², J. Tuttle², C. E. Haisch²
¹Pathology, The Brody School of Medicine at ECU, Greenville, NC, ²Surgery, The Brody School of Medicine at ECU, Greenville, NC
*Purpose: Our kidney transplant (KTx) program serves a medically underserved and racially diverse area of a southern state. The purpose of this study was to…
2020 American Transplant Congress
Choice of Mitral Valve and Aortic Valve for Replacement for ESRD Patients Eligible for Kidney Transplant: A USRDS Analysis
N. Sarabu¹, D. Ngendahimana², L. Al Dahabre³, K. Lentine⁴, K. Chavin¹, T. Srinivas¹, S. Deo²
¹University Hospitals Cleveland, Cleveland, OH, ²Case Western Reserve University, Cleveland, OH, ³University Hospitals of Cleveland, Cleveland, OH, ⁴Saint Louis University, Saint Louis, MO
*Purpose: Tissue valve (TiV) may be preferred over mechanical valve (meV) in ESRD patients for valve replacement. Among ESRD patients who are kidney transplant eligible,…
2020 American Transplant Congress
The Trend of Non-Utilization and Decline of Hepatitis C Virus Antibody-Positive Deceased Donor Kidneys
S. Chang¹, K. Lentine², D. Axelrod³, J. Wellen¹, M. Wang¹, M. A. Schnitzler⁴, T. Alhamad⁵
¹Surgery, Washington University School of Medicine, Saint Louis, MO, ²Surgery, Saint Louis University, Saint Louis, MO, ³Surgery, University of Iowa, Iowa City, IA, ⁴Surgery, Sanit Louis University, Saint Louis, MO, ⁵Washington University School of Medicine, Saint Louis, MO
*Purpose: With more transplant centers are accepting hepatitis C virus infected (HCV+) deceased donor kidneys (dHCV+), the trend of non-utilization and decline of these organs…